Drug Type Natural Killer Cell Therapies |
Synonyms- |
Target |
Action inhibitors |
Mechanism PRAME inhibitors(PRAME nuclear receptor transcriptional regulator inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Myeloid Tumor | Phase 2 | United States | 26 Jun 2024 |





